Latest filing published 10 Jul 2020 for Biohaven Pharmaceutical Holding Co Ltd., €3.7M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Robert Berman: trading record in brief
All filings by Robert Berman on record concern Biohaven Pharmaceutical Holding Co Ltd. Between 9 May 2017 and 8 July 2020, the trades on record add up to 86 filings.
Market trades split into 2 purchases (€94k) and 76 sales (€28.9M). Netting one side against the other leaves €28.8M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant and 7 option exercises. In 2020 alone, the filings show no purchases and 6 sales.
Most recently, on 10 July 2020, the filings show an open-market sale worth €3.7M in Biohaven Pharmaceutical Holding Co Ltd. The latest purchase dates back some time: it was published 2,690 days ago, on 28 June 2019. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Berman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 55,626 shares@ US$75.24825.4% of flowCommon SharesSEC:0001562180-20-005100:1
- 2,778 shares@ US$75.2861.3% of flowCommon SharesSEC:0001562180-20-005100:2
- 58,404 shares@ US$0.610.2% of flowCommon SharesSEC:0001562180-20-005100:0
- 4,296 shares@ US$0.610.0% of flowCommon SharesSEC:0001562180-20-004697:0
- 4,296 shares@ US$75.05382.0% of flowCommon SharesSEC:0001562180-20-004697:1
- 36,314 shares@ US$0.610.1% of flowCommon SharesSEC:0001562180-20-004627:0
- 25,000 shares@ US$5.600.9% of flowCommon SharesSEC:0001562180-20-004627:1
- 59,914 shares@ US$75.254927.6% of flowCommon SharesSEC:0001562180-20-004627:2
- 1,400 shares@ US$76.04820.7% of flowCommon SharesSEC:0001562180-20-004627:3
- 986 shares@ US$0.610.0% of flowCommon SharesSEC:0001562180-20-004627:4
- 986 shares@ US$75.06690.5% of flowCommon SharesSEC:0001562180-20-004627:5
- 125,000 shares@ US$0.610.5% of flowCommon SharesSEC:0001562180-19-006296:0
- 67,450 shares@ US$52.948121.8% of flowCommon SharesSEC:0001562180-19-006296:1
- 53,762 shares@ US$53.42917.5% of flowCommon SharesSEC:0001562180-19-006296:2
- 3,488 shares@ US$54.89171.2% of flowCommon SharesSEC:0001562180-19-006296:3
- 300 shares@ US$55.970.1% of flowCommon SharesSEC:0001562180-19-006296:4
- 625 shares0Common SharesSEC:0001689813-19-000136:0
- 284 shares@ US$52.130.1% of flowCommon SharesSEC:0001689813-19-000136:1
- 2,500 shares@ US$42.300.5% of flowCommon SharesSEC:0001209191-19-039411:0Canonical exit: 25 Sept 2019 (T+90)
- 10,647 shares@ US$37.071.3% of flowCommon SharesSEC:0001209191-18-037215:9
- 5,629 shares@ US$38.000.7% of flowCommon SharesSEC:0001209191-18-037215:10
- 1,671 shares@ US$36.010.2% of flowCommon SharesSEC:0001209191-18-037215:0
- 6,735 shares@ US$36.010.8% of flowCommon SharesSEC:0001209191-18-037215:1
- 1,218 shares@ US$35.250.1% of flowCommon SharesSEC:0001209191-18-037215:2
- 13,858 shares@ US$36.161.6% of flowCommon SharesSEC:0001209191-18-037215:3
25 of 81 declarations
